查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032849

疫苗管瓶市場：按類型、材質、產能、應用和地區分類的報告（2026-2034 年）

Vaccine Vials Market by Report Type (Multi Dose, Single Dose), Material (Glass, Polymer), Capacity (10ml, 20ml, 2ml, 3ml, 5ml), Application (Preventive Vaccine, Therapeutic Vaccine), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

2025年全球疫苗管瓶市場規模達7.555億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到15.356億美元，2026年至2034年的複合年成長率（CAGR）為7.95%。推動市場成長的主要因素包括感染疾病的蔓延、重大的技術創新、新疫苗的研發、全球人口的持續成長以及嚴格的品管措施。

疫苗管瓶是專門用於在無菌環境下儲存疫苗的玻璃或塑膠容器。這些管瓶經過精心製造，符合嚴格的品質和安全標準，確保疫苗在儲存和運輸過程中保持效力、有效性和穩定性。通常，疫苗管瓶配有密封蓋或塞子，可用注射器刺穿抽取疫苗，從而確保密封嚴實，最大限度地降低污染風險。根據疫苗類型和使用要求，疫苗管瓶可灌裝單劑量或多多劑量疫苗。管瓶使用的材料通常經過嚴格測試，以確保其不會與疫苗反應，並能維持疫苗的完整性。

感染疾病的蔓延是全球市場成長的主要驅動力之一。此外，對免疫規劃的日益重視也是重要的成長動力。這導致對疫苗儲存和分發用管瓶的需求持續成長。旨在提高疫苗保存期限和穩定性的管瓶材料和設計方面的技術創新也在推動市場成長。監管指南也發揮著至關重要的作用，更嚴格的品管措施和無菌要求促使製造商生產高品質的管瓶。世界衛生組織、全球疫苗免疫聯盟（GAVI）和各國衛生署等機構在醫療領域開展的疫苗接種宣傳活動等舉措，也促進了對疫苗管瓶的需求。人口成長和老化等人口因素導致老年人更容易感染疾病，進一步推動了需求成長。此外，物流和低溫運輸管理的進步使得疫苗分發更有效率和廣泛，間接推動了全球市場的發展。

疫苗管瓶市場的發展趨勢與促進因素：

擴大健康促進舉措和免疫接種計劃

對免疫規劃的日益重視是推動市場發展的最重要因素之一。世界衛生組織（WHO）、全球疫苗免疫聯盟（Gavi）等組織、各國政府都在大力投資旨在根除或控制感染疾病的免疫宣傳活動。這些努力導致對疫苗管瓶的需求激增，疫苗瓶對於疫苗的安全儲存、運輸和分發至關重要。此外，諸如新冠肺炎疫情等新型感染疾病的爆發也需要緊急進行大規模免疫接種活動，進一步加劇了疫苗管瓶市場的壓力。

材料和設計方面的重大技術進步

疫苗管瓶設計和材料的創新是推動市場成長的另一個關鍵因素。目前正在研發的先進玻璃和聚合物材料具有更強的抗破損、抗污染和抗與疫苗活性成分相互作用的能力。這些創新不僅提高了疫苗的安全性和有效性，還延長了保存期限，從而提高了疫苗的可及性，尤其是在偏遠地區。

加強監管合規性和品質保證

疫苗儲存和運輸方面的嚴格規定也推動了對高品質疫苗管瓶的需求。監管機構制定了嚴格的品管和無菌要求，鼓勵生產商生產符合或超過這些標準的管瓶。這種對品質保證的重視確保疫苗在最佳條件下儲存，從而保持其有效性並最大限度地減少劣化和浪費。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球疫苗管瓶市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 多劑量
  • 單一劑量

第7章 市場區隔：依材料分類

  • 玻璃
  • 聚合物

第8章 市場區隔：依銷量

  • 10ml
  • 20ml
  • 2ml
  • 3ml
  • 5ml

第9章 市場區隔：依應用領域分類

  • 預防性疫苗
  • 治療性疫苗

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Anhui Huaxin Medicinal Glass Products Co. Ltd.
    • Berlin Packaging LLC
    • Corning Incorporated
    • DWK Life Sciences GmbH
    • Gerresheimer AG
    • Jinan Youlyy Industrial Co. Ltd.
    • JOTOP Glass
    • Richland Glass Company
    • Schott AG
    • Shandong Pharmaceutical Glass Co. Ltd.
    • Stevanato Group
Product Code: SR112026A6599

The global vaccine vials market size reached USD 755.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,535.6 Million by 2034, exhibiting a growth rate (CAGR) of 7.95% during 2026-2034. The increasing prevalence of infectious diseases, significant technological innovations, the development of new vaccines, the steadily increasing global population, and strict quality control measures are some of the major factors propelling the market.

Vaccine vials are specialized glass or plastic containers designed to store vaccines in a sterile environment. These vials are meticulously crafted to meet strict quality and safety standards, ensuring that the vaccine's potency, efficacy, and stability are maintained during storage and transportation. Generally, vaccine vials come with a sealed cap or stopper that can be punctured by a syringe for vaccine extraction, thus ensuring a closed system that minimizes contamination risks. They can contain either single-dose or multi-dose quantities, depending on the type and usage requirements of the vaccine. The material used for the vials is often subjected to rigorous testing to ensure it does not interact with the vaccine, preserving its integrity.

The increasing prevalence of infectious diseases represents one of the key factors driving the growth of the market across the globe. This, coupled with the rising focus on immunization programs is acting as a major growth-inducing factor. This creates a consistent demand for vaccine vials to facilitate the storage and distribution of vaccines. The market is also driven by technological innovation in vial materials and design, aimed at enhancing the shelf-life and stability of vaccines. Regulatory guidelines also play a crucial role with stricter quality control measures and sterility requirements which are influencing manufacturers to produce high-quality vials. The rising healthcare initiatives, such as vaccination campaigns by organizations like the WHO, GAVI, the Vaccine Alliance, and national health departments of various countries, are fueling the need for vaccine vials. Demographic factors, including population growth and an aging population more susceptible to diseases, are adding another layer of demand. Moreover, advancements in distribution logistics and cold chain management allow for more effective and far-reaching vaccine distribution, which is indirectly driving the market across the globe.

VACCINE VIALS MARKET TRENDS/DRIVERS:

Rising health initiatives and immunization programs

The growing emphasis on immunization programs is one of the most significant drivers in the market. Organizations, such as the World Health Organization (WHO) and Gavi, as well as national governments, are investing heavily in vaccination campaigns to eradicate or control infectious diseases. These initiatives generate a high demand for vaccine vials as they are essential for the safe storage, transportation, and delivery of vaccines. Furthermore, outbreaks of new infectious diseases, such as the COVID-19 pandemic, result in urgent, large-scale immunization efforts, putting additional demand pressure on the vaccine vials market.

Significant technological advancements in material and design

Innovations in the design and materials used for vaccine vials is another key factor driving the market growth. Advanced glass and polymer materials that are more resistant to breakage, contamination, and interaction with the vaccine's active ingredients are being developed. These innovations not only enhance the safety and efficacy of vaccines but also extend their shelf life, thus making vaccines more accessible, particularly in remote areas.

Rise in regulatory compliance and quality assurance

Stringent regulations regarding vaccine storage and transportation also drive the need for high-quality vaccine vials. Regulatory bodies are imposing rigorous quality control and sterility requirements, which is influencing manufacturers to produce vials that meet or exceed these standards. The emphasis on quality assurance ensures that vaccines are stored in optimal conditions, preserving their effectiveness, and minimizing waste due to spoilage.

VACCINE VIALS INDUSTRY SEGMENTATION:

Breakup by Type:

  • Multi Dose
  • Single Dose

Multi dose represents the largest market segment

Multi-dose vials are generally more cost-efficient than single-dose vials as they utilize less packaging material and occupy less storage space. This makes them economically attractive, particularly for large-scale immunization programs. In situations where mass vaccination is required, such as pandemic response or routine immunization programs, multi-dose vials allow for the quick and efficient vaccination of many individuals. This is especially relevant in low-resource settings where rapid administration is crucial. Multi-dose vials are easier to transport and store, which is particularly important in regions with limited cold chain infrastructure. Their compact size and lesser weight compared to an equivalent number of single-dose vials make them more manageable in logistics operations. Utilizing multi-dose vials can reduce medical waste, as fewer vials are needed to deliver the same number of doses. This is an attractive feature from an environmental sustainability perspective. Many health organizations advocate for the use of multi-dose vials under controlled conditions to extend the reach of vaccination programs, thereby driving demand.

Breakup by Material:

  • Glass
  • Polymer

Glass represents the largest market segment A detailed breakup and analysis of the market based on the material has also been provided in the report. This includes glass and polymer. According to the report, glass accounted for the largest market share.

The widespread adoption of glass as a primary material in the vaccine vials market is underpinned by several influential factors that underscore its prominence. Foremost is the material's exceptional compatibility with pharmaceutical products, ensuring the preservation of vaccine integrity and efficacy. Glass offers an inert and non-reactive environment, preventing chemical interactions that could compromise the vaccine's composition. The impermeability of glass to gases and moisture safeguards against contamination, maintaining the sterile conditions vital for vaccine stability. Additionally, glass vials are amenable to aseptic filling processes, minimizing the risk of microbial intrusion. The transparency of glass aids in accurate dosage measurement and visual inspection of contents. Furthermore, glass is recyclable and environmentally responsible, aligning with sustainability objectives.

Breakup by Capacity:

  • 10ml
  • 20ml
  • 2ml
  • 3ml
  • 5ml

The vaccine vials market segmentation based on 10ml capacity addresses the need for efficient storage and administration of vaccines that require larger doses. These vials are ideal for multi-dose vaccines and mass immunization campaigns, as they allow for precise dosage measurement and reduced wastage. The 10ml capacity segment caters to healthcare scenarios where accurate dosing, ease of distribution, and optimized resource utilization are pivotal. This segmentation ensures that vaccines with higher dosage requirements can be effectively stored, transported, and administered, thus contributing to streamlined vaccination efforts and effective public health outcomes.

Based on 20ml capacity, the vaccine vials market segmentation addresses the demand for efficient storage and administration of vaccines requiring larger doses. These vials are suitable for multi-dose vaccines and mass vaccination campaigns, ensuring precise dosing and minimizing wastage. The 20ml capacity segment meets healthcare needs where accurate dosing, streamlined distribution, and optimal resource usage are essential. This segmentation facilitates the storage, transportation, and dispensing of vaccines with higher dosage requirements, thus contributing to effective immunization initiatives and public health outcomes.

On the basis of 2ml capacity, the vaccine vials market segmentation addresses the demand for precise dosing and efficient administration of vaccines with smaller doses. These vials are well-suited for single-dose vaccines and pediatric applications, ensuring accurate dosage measurement and minimal wastage. The 2ml capacity segment caters to scenarios where precise dosing, ease of use, and minimizing contamination risks are critical. This segmentation facilitates the storage, transportation, and delivery of vaccines requiring smaller doses, which contributes to effective immunization strategies and healthcare outcomes, particularly for vulnerable populations such as children.

The vaccine vials market segmentation based on 3ml capacity caters to the need for accurate dosing and efficient delivery of vaccines requiring moderate-sized doses. These vials are suitable for single-dose vaccines and applications where precise measurement is crucial. The 3ml capacity segment addresses healthcare scenarios that demand reliable dosing, convenient handling, and reduced risk of contamination. This segmentation facilitates the storage, transportation, and administration of vaccines with intermediate dosage requirements, thereby contributing to effective immunization strategies and healthcare outcomes for various patient populations.

Based on 5ml capacity, the vaccine vials market segmentation caters to the versatility of vaccine dosing requirements. These vials accommodate a range of vaccine formulations and dosages, thus making them suitable for various applications, including routine immunizations and special campaigns. The 5ml capacity segment is chosen in scenarios where flexibility, efficient storage, and streamlined distribution are essential. This segmentation allows for the storage, transportation, and precise administration of vaccines with diverse dosage needs, which contributes to effective vaccination efforts and healthcare outcomes for different patient populations.

Breakup by Application:

  • Preventive Vaccine
  • Therapeutic Vaccine

Preventive vaccines are designed to proactively protect individuals from infectious diseases by stimulating the immune system to develop immunity against specific pathogens. Preventive vaccines target a wide array of diseases, ranging from common childhood illnesses like measles, mumps, and rubella to more complex diseases, such as influenza and human papillomavirus. The use of vaccine vials in this context is pivotal, ensuring that the vaccines remain stable, effective, and ready for administration when needed. The market's segmentation based on preventive vaccines considers the diverse spectrum of immunization needs and their critical role in preventing the spread of communicable diseases. Preventive vaccines play a pivotal role in reducing the burden of infectious diseases and curbing epidemics. The availability of vaccine vials tailored to their specific dosing needs contributes to accurate dosing, streamlined distribution, and effective immunization campaigns.

Therapeutic vaccines are administered after a person has already contracted a disease. These vaccines aim to modulate the immune response and assist the body in fighting the disease more effectively. Therapeutic vaccines are developed for diseases like cancer, where the immune system's response is directed towards eliminating cancerous cells. The application of vaccine vials in the therapeutic context emphasizes the importance of maintaining vaccine integrity, stability, and dosing precision to ensure that the therapeutic effects are optimized. Therapeutic vaccines are less common than preventive vaccines and offer promise in addressing various medical challenges. The use of vaccine vials in this context is essential for ensuring the appropriate storage and administration of these specialized treatments. The ability to deliver therapeutic vaccines accurately and reliably is critical in achieving desired therapeutic outcomes.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America accounted for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

In North America, the vaccine vials market is significantly influenced by several key factors. Primarily, the robust healthcare infrastructure and a strong emphasis on immunization programs in the region are creating consistent demand for high-quality vaccine vials. Technological innovation is a major driver, with companies investing in research and development (R&D) to produce advanced vial materials and designs that enhance vaccine storage and longevity. Regulatory compliance also plays a crucial role with strict FDA guidelines on vaccine storage requiring vials that meet high-quality standards, further driving the market. The presence of major pharmaceutical companies and frequent launches of new vaccines contribute to the steady growth of the vaccine vials market in North America.

COMPETITIVE LANDSCAPE:

Key market players in the vaccine vials market are actively engaged in various strategies to strengthen their market position. One predominant focus is on research and development (R&D) to create advanced vial materials and designs that enhance vaccine preservation and usability. Companies are increasingly adopting materials like borosilicate glass and high-grade plastics that are less prone to interaction with the vaccine, ensuring potency and stability over extended periods. Many companies are entering into partnerships or acquisitions to bolster their manufacturing capacities and geographic reach. Quality assurance remains a critical area of investment, with companies intensifying their efforts to comply with stringent regulatory standards for sterility and durability. Automation in quality checks is also being adopted for higher efficiency and consistency. Additionally, key players are actively participating in global healthcare initiatives and are collaborating with organizations and governments to provide vials for large-scale vaccination programs. Companies are focusing on sustainability by exploring eco-friendly materials and recycling programs, acknowledging the environmental impact of vial production.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Anhui Huaxin Medicinal Glass Products Co. Ltd.
  • Berlin Packaging LLC
  • Corning Incorporated
  • DWK Life Sciences GmbH
  • Gerresheimer AG
  • Jinan Youlyy Industrial Co. Ltd.
  • JOTOP Glass
  • Richland Glass Company
  • Schott AG
  • Shandong Pharmaceutical Glass Co. Ltd.
  • Stevanato Group.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Vaccine Vials Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Multi Dose
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Single Dose
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Material

  • 7.1 Glass
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polymer
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Capacity

  • 8.1 10ml
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 20ml
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 2ml
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 3ml
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 5ml
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Preventive Vaccine
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Therapeutic Vaccine
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Anhui Huaxin Medicinal Glass Products Co. Ltd.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Berlin Packaging LLC
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Corning Incorporated
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 DWK Life Sciences GmbH
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Gerresheimer AG
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Jinan Youlyy Industrial Co. Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 JOTOP Glass
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Richland Glass Company
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Schott AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 SWOT Analysis
    • 15.3.10 Shandong Pharmaceutical Glass Co. Ltd.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Stevanato Group
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials

List of Figures

  • Figure 1: Global: Vaccine Vials Market: Major Drivers and Challenges
  • Figure 2: Global: Vaccine Vials Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Vaccine Vials Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Vaccine Vials Market: Breakup by Material (in %), 2025
  • Figure 6: Global: Vaccine Vials Market: Breakup by Capacity (in %), 2025
  • Figure 7: Global: Vaccine Vials Market: Breakup by Application (in %), 2025
  • Figure 8: Global: Vaccine Vials Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Vaccine Vials (Multi Dose) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Vaccine Vials (Multi Dose) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Vaccine Vials (Single Dose) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Vaccine Vials (Single Dose) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Vaccine Vials (Glass) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Vaccine Vials (Glass) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Vaccine Vials (Polymer) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Vaccine Vials (Polymer) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Vaccine Vials (10ml) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Vaccine Vials (10ml) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Vaccine Vials (20ml) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Vaccine Vials (20ml) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Vaccine Vials (2ml) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Vaccine Vials (2ml) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Vaccine Vials (3ml) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Vaccine Vials (3ml) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Vaccine Vials (5ml) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Vaccine Vials (5ml) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Vaccine Vials (Preventive Vaccine) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Vaccine Vials (Preventive Vaccine) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Vaccine Vials (Therapeutic Vaccine) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Vaccine Vials (Therapeutic Vaccine) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: North America: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: North America: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: United States: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: United States: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Canada: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Canada: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Asia-Pacific: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Asia-Pacific: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: China: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: China: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Japan: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Japan: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: India: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: India: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: South Korea: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: South Korea: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Australia: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Australia: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Indonesia: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Indonesia: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Others: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Others: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Europe: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Europe: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Germany: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Germany: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: France: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: France: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: United Kingdom: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: United Kingdom: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Italy: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Italy: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Spain: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Spain: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Russia: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Russia: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Others: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Others: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Latin America: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Latin America: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Brazil: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Brazil: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Mexico: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Mexico: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Others: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Others: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Middle East and Africa: Vaccine Vials Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Middle East and Africa: Vaccine Vials Market: Breakup by Country (in %), 2025
  • Figure 79: Middle East and Africa: Vaccine Vials Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Global: Vaccine Vials Industry: SWOT Analysis
  • Figure 81: Global: Vaccine Vials Industry: Value Chain Analysis
  • Figure 82: Global: Vaccine Vials Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Vaccine Vials Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Vaccine Vials Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Vaccine Vials Market Forecast: Breakup by Material (in Million USD), 2026-2034
  • Table 4: Global: Vaccine Vials Market Forecast: Breakup by Capacity (in Million USD), 2026-2034
  • Table 5: Global: Vaccine Vials Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 6: Global: Vaccine Vials Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Vaccine Vials Market: Competitive Structure
  • Table 8: Global: Vaccine Vials Market: Key Players